Pfizer cut to sell by Citi, target to $31
Citi downgraded Pfizer (NYSE: PFE) from Neutral to Sell with a price target of $31.00 (from $38.00).
Analyst Andrew Baum said the company needs a deal to deliver on consensus EPS. The firm cut non-GAAP EPS estimates by 5%-10% (2018-22), and their non-GAAP EPS estimates are now 12% below consensus in 2022.
Advertisements
Leave a Comment